Skytrofa
Drug
Ascendis Pharma Inc
Total Payments
$3.4M
Transactions
2,753
Doctors
657
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $3.1M | 2,715 | 657 |
| 2023 | $306,754 | 38 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $3.0M | 978 | 88.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $258,540 | 90 | 7.7% |
| Food and Beverage | $46,080 | 1,506 | 1.4% |
| Travel and Lodging | $45,425 | 169 | 1.3% |
| Consulting Fee | $30,319 | 10 | 0.9% |
Payments by Type
Research
$3.0M
978 transactions
General
$380,363
1,775 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| New InsiGHts | Ascendis Pharma Inc | $1.1M | 0 |
| SkybriGHt | Ascendis Pharma Inc | $552,858 | 1 |
| SkyPASS | Ascendis Pharma Inc | $540,885 | 1 |
| foresiGHt extension | Ascendis Pharma Inc | $530,509 | 0 |
| foresiGHt | Ascendis Pharma Inc | $297,518 | 0 |
| enliGHten | Ascendis Pharma Inc | $11,966 | 0 |
Top Doctors Receiving Payments for Skytrofa — Page 6
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| , MD | Pediatrics | Cincinnati, OH | $121.04 | 1 |
| , FNP | Nurse Practitioner | Hawthorne, NY | $119.86 | 5 |
| Payal Patel | Pediatric Endocrinology | Stony Brook, NY | $118.93 | 5 |
| , MD | Pediatrics | New Hyde, NY | $118.62 | 5 |
| , M.D.,PH.D | Pediatrics | New Hyde Park, NY | $118.62 | 5 |
| , DO | Pediatrics | Boston, MA | $117.76 | 1 |
| , M.D | Student in an Organized Health Care Education/Training Program | Edinburg, TX | $116.55 | 1 |
| , M.D | Pediatrics | Tenafly, NJ | $115.55 | 7 |
| , DNP, APRN FNP-BC | Family | San Antonio, TX | $115.27 | 5 |
| , M.B.B.S | Endocrinology, Diabetes & Metabolism | Plano, TX | $111.39 | 5 |
| , MD | Pediatrics | Orange, CA | $111.02 | 4 |
| , M.D | Student in an Organized Health Care Education/Training Program | La Crosse, WI | $110.74 | 1 |
| , MD | Pediatric Endocrinology | Charlotte, NC | $109.10 | 1 |
| David Segal | Pediatric Endocrinology | Fort Wayne, IN | $108.80 | 1 |
| , MD | Pediatric Endocrinology | Newark, NJ | $105.52 | 1 |
| , MD | Pediatric Endocrinology | Houston, TX | $105.38 | 6 |
| , PA-C | Medical | Edinburg, TX | $101.91 | 5 |
| , M.D | Pediatrics | New Hyde Park, NY | $101.29 | 4 |
| , M.D | Pediatrics | Bronx, NY | $100.94 | 3 |
| , M.D | Pediatric Gastroenterology | East Lansing, MI | $100.01 | 5 |
| , MD | Pediatric Endocrinology | Houston, TX | $97.97 | 4 |
| , MD | Pediatric Endocrinology | Orlando, FL | $96.64 | 1 |
| , MD | Pediatric Endocrinology | Orlando, FL | $96.64 | 1 |
| , MD | Pediatric Endocrinology | Orlando, FL | $96.64 | 1 |
| , MD | Pediatric Endocrinology | Orlando, FL | $96.64 | 1 |
Ad
Manufacturing Companies
- Ascendis Pharma Inc $3.4M
Product Information
- Type Drug
- Total Payments $3.4M
- Total Doctors 657
- Transactions 2,753
About Skytrofa
Skytrofa is a drug associated with $3.4M in payments to 657 healthcare providers, recorded across 2,753 transactions in the CMS Open Payments database. The primary manufacturer is Ascendis Pharma Inc.
Payment data is available from 2023 to 2024. In 2024, $3.1M was paid across 2,715 transactions to 657 doctors.
The most common payment nature for Skytrofa is "Unspecified" ($3.0M, 88.7% of total).
Skytrofa is associated with 6 research studies, including "New InsiGHts" ($1.1M).